Key takeaways
Many adults haven’t heard of respiratory syncytial virus (RSV). This is surprising since this common respiratory virus sends more people to the hospital than the flu does.
In older adults (aged 75+) and adults (aged 50-74) with certain risk factors like heart disease, diabetes, or chronic lung conditions, RSV can be especially serious, with complications like functional decline, pneumonia, and heart problems. These complications result in tens of thousands of hospitalizations each year.
Although there are no prescription treatments for RSV, preventive care, including a single-dose vaccination, can help reduce the risk of developing severe illness.
110K+
Adults aged 50 and older hospitalized by RSV
Each year, RSV leads to an estimated 110,000–180,000 hospitalizations among adults aged 50 and older in the United States.
What is RSV?
RSV, which stands for respiratory syncytial virus, is a common virus that infects the nose, throat, respiratory tract, and lungs. Most people will get RSV at some point in their lives, often more than once, because immunity after infection is limited.
How does RSV spread?
RSV spreads easily through coughs, sneezes, and by touching contaminated surfaces. People can pass the virus on before they feel sick, which helps it spread quickly in households and communities. RSV typically circulates during the fall and winter months.
How does the immune system respond to RSV?
When RSV enters the body, the immune system first mounts an immediate defense by releasing antiviral signals and recruiting immune cells to help control the infection. It then builds a more targeted response by producing antibodies and activating T cells to clear the virus.
Some people can recover with mild symptoms. Others, like those with weakened immune systems or chronic health conditions, may become seriously ill because their bodies are naturally less able to control the virus.
How is RSV different from a cold or the flu?
RSV can feel like a cold or the flu at first, with runny nose, coughing, and a mild fever being common early symptoms. Unlike a cold or the flu, RSV is more likely to affect the lower lungs and, in some cases, lead to more serious complications such as pneumonia, bronchitis, or heart problems.
In fact, nearly 1 in 4 hospitalized adults aged 50+ with RSV experienced a sudden cardiac event. RSV can also progress from mild symptoms to more severe illness, particularly in people at higher risk.
RSV affects millions of people worldwide each year and is one of the more significant causes of serious respiratory illness in older adults.
What are the symptoms of RSV?
RSV symptoms often start mild and can worsen over time, especially if the infection moves deeper into the lungs.
Common symptom progression:
- Early symptoms may include: Runny nose, cough, sneezing, and mild fever.
- More advanced symptoms may include: Wheezing, persistent cough, difficulty breathing, fatigue, and reduced appetite.
Even though early RSV symptoms may be mild and easy to manage on your own, if they progress in severity to wheezing or difficulty breathing, that can signal a more serious illness that may require treatment from a healthcare provider.
How symptoms can vary by group
Symptoms are not always the same for everyone:
- Infants and young children: May experience feeding difficulties, irritability, decreased activity, and breathing problems. In some children, symptoms become more severe after a few days and can progress to wheezing, bronchiolitis, or pneumonia.
- Healthy adults: Often experience mild, flu-like symptoms including runny nose, cough, sneezing, low-grade fever, and reduced appetite.
- Older adults: May begin like the flu, but is more likely to develop severe symptoms, including breathing difficulties, worsening fatigue, and complications like pneumonia or heart problems.
- Immunocompromised individuals: Higher risk of more severe illness, complications, or a faster progression of symptoms.
Who is at risk of getting RSV?
RSV is a common virus that can affect anyone, including adults, although certain groups are more likely to develop severe symptoms or complications. Higher-risk groups include:
- Older adults, particularly those aged 75 and older
- Adults aged 50–74 with underlying health conditions, such as heart disease, diabetes, chronic lung conditions (like chronic obstructive pulmonary disease, also known as COPD), or kidney disease
- Infants under 6 months, especially those born prematurely
- Children under 5
- People with weakened immune systems
For these groups, RSV can lead to pneumonia or a hospital stay. It can also make other conditions worse, like asthma, COPD, or heart failure.
Lower-risk groups include:
- Healthy adults
- Older children and teenagers
While RSV is often mild in these groups, it can still become serious in some cases, particularly if symptoms worsen or if other health conditions are present.
What are the potential complications of RSV?
RSV can affect more than just the lungs and can lead to complications, particularly in higher-risk groups. When the infection spreads to the lower respiratory tract (the airways and lungs), it can cause pneumonia, bronchitis, or bronchiolitis, which may require hospital care.
Beyond the lungs, RSV can also affect the heart and blood vessels. In some adults, RSV can make existing heart conditions worse and trigger an irregular heartbeat (arrhythmia). In rare cases, it can cause inflammation in the heart muscle (myocarditis).
1/4
Adults hospitalized with RSV experienced sudden cardiac events
Nearly 1 in 4 hospitalized adults aged 50+ with RSV experienced a sudden cardiac event (e.g., heart failure).
How is RSV treated?
There are no approved prescription treatments for RSV in adults. Care focuses on managing symptoms while the body works to clear the virus.
Most mild to moderate cases can be managed at home with rest, fluids, and over-the-counter medications to reduce fever or discomfort.
In more severe cases, hospitalization may be required. Hospital treatment may include oxygen support, IV fluids, or breathing support to help the body recover.
Because treatment options are limited, prevention plays an important role. Vaccination can help reduce the risk of severe illness, especially for those at higher risk.
You can learn more about vaccination in the RSV vaccine guide or use VaxAssist by Pfizer to check your eligibility and book an appointment.
Who is eligible for the RSV vaccine?
In the United States, RSV vaccination is recommended for adults at higher risk of severe illness. This includes:
- All adults aged 75 and older
- Adults aged 50 to 74 at increased risk of severe RSV illness, due to certain underlying medical conditions such as heart disease, chronic lung conditions (like COPD or asthma), diabetes, or kidney disease
These recommendations are based on guidance from the Centers for Disease Control and Prevention (CDC).
Because there are no approved prescription treatments for RSV, prevention plays an important role. Vaccination may not prevent every infection, but it can help reduce the risk of severe illness and complications, including hospitalization. As with any vaccine, side effects can occur, but they are typically mild and short-lived, such as soreness at the injection site, fatigue, or headache.
When should you see a doctor about RSV?
Most RSV infections are mild, but it’s important to know when to seek care and how to reduce your risk of severe illness.
Contact a healthcare provider if:
- Symptoms are worsening or not improving
- You or someone in your care is at higher risk
- You are unsure whether symptoms could be RSV
Call emergency services or seek immediate care if there are signs of severe illness, including:
- Difficulty breathing
- Chest pain or pressure
- Bluish lips or face
- Severe dehydration
- Confusion or difficulty staying awake
Knowing the symptoms, understanding your risk, and taking steps to protect yourself can make a difference. Check your eligibility and book an RSV vaccination in minutes using VaxAssist by Pfizer.
Frequently
asked questions
Why do I only need one dose of the RSV vaccine?
You only need one dose because RSV vaccines are designed to help protect against severe illness without requiring a multi‑dose series. RSV is most common in the fall and winter months, and vaccination works best if given in late summer to early fall. However, you can get vaccinated at any time of year, and there’s no need to wait until the season begins. Your healthcare provider can advise if additional doses are needed in the future.
Can I spread RSV to others if I don’t have symptoms?
Yes, it is possible to spread RSV even if symptoms are mild or not yet noticeable. People can be contagious before they feel sick, which is why RSV can spread quickly within households and communities.
Can I get the RSV vaccine at the same time as other vaccines?
Yes, you can get the RSV vaccine at the same time as some other routine vaccines. In some cases, getting vaccines together may increase the chance of common side effects, such as soreness at the injection site, fatigue, or headache, but these are typically mild and short-lived. If you have any questions about what’s right for you, a healthcare provider can help guide the decision. Learn more in Getting more than one vaccine: important information to consider.
Are all RSV vaccines the same?
No, RSV vaccines can differ in how they are designed, including the way they trigger an immune response and who they are intended for. Some are designed for older adults, while others are given during pregnancy to protect infants. A healthcare provider can help determine which option is most appropriate based on age, health status, and risk factors.
There are no approved prescription treatments for RSV. Care focuses on managing symptoms while the body clears the virus.
Find out more about the importance of RSV vaccination:
Correct answer: There are no approved prescription treatments for RSV. Care focuses on managing symptoms while the body clears the virus.
Find out more about the importance of RSV vaccination:
More relevant articles
Keep reading
- /vaccines/education/what-is-the-rsv-vaccine
- /vaccines/education/more-than-one-vaccine
- /vaccines/education/aging-and-immune-system
- /vaccines/education/what-is-in-vaccines
References
American Heart Association. RSV and Heart Health. Reviewed July 30, 2025. Accessed June 11, 2026. https://www.heart.org/en/health-topics/rsv
American Lung Association. RSV is the leading cause of hospitalization in babies; how to protect your baby this winter. Published October 2, 2024. Accessed June 12, 2026. https://www.lung.org/media/press-releases/fy25-rsv-in-babies-campaign-(1)
American Lung Association. RSV symptoms and diagnosis. Updated January 27, 2026. Accessed June 11, 2026. https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv/symptoms-diagnosis
American Lung Association. RSV for Healthcare Providers. Accessed June 29, 2026. https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv/rsv-hcp#:~:text=Respiratory%20syncytial%20virus%20(RSV)%20causes,for%20adults%20in%20June%202023
Centers for Disease Control and Prevention (CDC). About RSV. December 30, 2025. Accessed June 11, 2026. https://www.cdc.gov/rsv/about/index.html
Centers for Disease Control and Prevention (CDC). How RSV spreads. February 20, 2026. Accessed June 11, 2026. https://www.cdc.gov/rsv/causes/index.html
Centers for Disease Control and Prevention (CDC). RSV in adults. February 20, 2026. Accessed June 11, 2026. https://www.cdc.gov/rsv/adults/index.html
Centers for Disease Control and Prevention (CDC). RSV in infants and young children. February 20, 2026. Accessed June 11, 2026. https://www.cdc.gov/rsv/infants-young-children/index.html
Centers for Disease Control and Prevention (CDC). RSV vaccine guidance for adults. February 24, 2026. Accessed June 17, 2026. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html
Centers for Disease Control and Prevention (CDC). Symptoms and care of RSV. February 20, 2026. Accessed June 11, 2026. https://www.cdc.gov/rsv/symptoms/index.html
Centers for Disease Control and Prevention (CDC). Clinical guidance for RSV immunizations and vaccines. August 18, 2025. June 11, 2026. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/index.html
Centers for Disease Control and Prevention (CDC). Clinical overview of RSV. August 18, 2025. Accessed June 17, 2026. https://www.cdc.gov/rsv/hcp/clinical-overview/index.html
Kim T, Choi SH. Epidemiology and disease burden of respiratory syncytial virus infection in adults. Infect Chemother. 2024;56(1):1. doi:10.3947/ic.2024.0011
Liang C, Zhou Y, Kent M, Chilson EL, Gessner BD, Begier E. Intensive care unit stay and mechanical ventilation among adults with respiratory syncytial virus-related hospitalization by age and comorbidity status. Infect Dis Ther. 2026;15(1):101-115
Mayo Clinic. Respiratory syncytial virus (RSV). October 4, 2023. Accessed June 17, 2026. https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/symptoms-causes/syc-20353098
Milas, Anamaria, et al. Respiratory syncytial virus associated myocarditis requiring venoarterial extracorporeal membrane oxygenation. Case Reports in Infectious Diseases 2017. 2017:7074508
National Health Service (NHS). Respiratory syncytial virus (RSV). Reviewed July 5, 2024. Accessed June 17, 2026. https://www.nhs.uk/conditions/respiratory-syncytial-virus-rsv/
Russell CD, Unger SA, Walton M, Schwarze J. The human immune response to respiratory syncytial virus infection. Clin Microbiol Rev. 2017;30(2):481-502. doi:10.1128/CMR.00090-16
World Health Organization (WHO). Respiratory syncytial virus (RSV). December 19, 2025. Accessed June 11, 2026. https://www.who.int/news-room/fact-sheets/detail/respiratory-syncytial-virus-%28rsv%29
World Health Organization (WHO). Respiratory syncytial virus - global. Accessed June 17, 2026. https://www.who.int/health-topics/respiratory-syncytial-virus#tab=tab_1
Woodruff RC, Melgar M, Pham H, et al. Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection. JAMA Intern Med. 2024;184(6):602. doi:10.1001/jamainternmed.2024.0212